1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60291B1DAB54F90EA85256E43007A3701
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/key-factors-in-successful-global-pharmaceutical-launches?opendocument
18
19opendocument
2034.236.145.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Product Launch Excellence

Key Factors in Successful Global Pharmaceutical Launches

DB Image

ID: 4564


Features:

Graphics


Pages/Slides: 5


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Integrated global marketing launch systems generate rapid sales uptake and help produce blockbuster products that realize their maximum economic potential in the global marketplace. This five-page document includes the key lessons learned from a benchmark study on global product launches. This study covered an elite group of high-performing products introduced by leading pharmaceutical companies.

Pharmaceutical launch teams can use the information in this document to create an integrated global marketing launch system.

Key topics include:
-Launch strategy and structure
-Managing cross-functional teams
-Thought leader development
-Sales force support
-Life cycle management

Select best practices include:
-Consistently allocate sufficient resources to support global launch and rapid uptake of high-potential drugs.
-Manage thought leader programs as an integrated, multi-phased process to shape clinical development and market acceptance.
-Employ innovative market research to enhance product positioning and brand development.

This research originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device


Companies Profiled:
Sanofi-aventis; Merck; Eli Lilly; GlaxoSmithKline; Novartis; Pfizer; Johnson & Johnson; Bristol-Myers Squibb; AstraZeneca; Roche; Schering-Plough


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.